Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price ...

The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...

Eli Lilly and Novo Nordisk the pharmaceutical heavyweights selling popular weight-loss injections are each dangling discounts to gain an edge and to ...

The company shipped some 750 vials of testosterone to customers who had instead ordered ... struggled to meet demand after ...

Related Study: Ozempic, Wegovy can boost health beyond weight loss Lilly cuts price on weight-loss drug Zepbound, selling it in single-dose vials Study shows shift in GLP-1 drug use for obesity ...

(Weight loss drug Wegovy is also a semaglutide medication ... a four-week supply of 2.5 milligrams of Zepbound (or $99.75 per vial). However, a four-week supply of the 5 milligram dose will ...

1 These single-dose vials are priced at a 50% or greater discount ... which was about 20% lower than that of Novo Nordisk’s semaglutide (Wegovy) 2.4 mg injection for weight loss; 4 the list ...

“These new vials not only help us meet the high demand ... Lilly and Novo Nordisk, the maker of Ozempic and Wegovy, have been under pressure to lower the cost of their hugely popular — but ...

The lowest dose of Novo's Wegovy used to start new patients remains listed as in shortage. Patrik Jonsson, Lilly's president of cardiometabolic health, said in an interview that the vials launch ...

Related Lilly cuts price on weight-loss drug Zepbound, selling it in single-dose vials Under new Medicare rules, 3.6M Americans could be covered for Wegovy Ozempic may have added benefit of ...

Patients using its new vial will need to buy their own syringes ... Currently Zepbound and Novo Nordisk’s Wegovy are on the US Food and Drug Administration’s shortages list.